Trexquant Investment LP Pliant Therapeutics, Inc. Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
A detailed history of Trexquant Investment LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 62,477 shares of PLRX stock, worth $203,675. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,477
Previous 86,852
28.06%
Holding current value
$203,675
Previous $973,000
15.52%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$19.5 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$16.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$15.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$10.5 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$10.4 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $159M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...